396 related articles for article (PubMed ID: 7797401)
1. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats.
Hirano S; Wakazono K; Agata N; Mase T; Yamamoto R; Matsufuji M; Sakata N; Iguchi H; Tone H; Ishizuka M
Int J Tissue React; 1994; 16(4):155-62. PubMed ID: 7797401
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytogenin on spontaneous arthritis in MRL/1 mice and on pristane-induced arthritis (PIA) in DBA/1J mice.
Abe C; Hirano S; Wakazono K; Mase T; Yamamoto R; Matsufuji M; Sakata N; Agata N; Iguchi H; Ishizuka M
Int J Tissue React; 1995; 17(5-6):175-80. PubMed ID: 8835627
[TBL] [Abstract][Full Text] [Related]
3. Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. II. Effect on type II collagen-induced arthritis in mice.
Matsumoto N; Iinuma H; Sawa T; Takeuchi T; Hirano S; Yoshioka T; Ishizuka M
J Antibiot (Tokyo); 1997 Nov; 50(11):906-11. PubMed ID: 9592561
[TBL] [Abstract][Full Text] [Related]
4. Effect of pine pollen extract on experimental chronic arthritis.
Lee KH; Choi EM
Phytother Res; 2009 May; 23(5):651-7. PubMed ID: 19148883
[TBL] [Abstract][Full Text] [Related]
5. Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology.
Rordorf C; Pataki A; Nogues V; Schlager F; Feige U; Glatt M
Int J Tissue React; 1987; 9(4):341-7. PubMed ID: 3623829
[TBL] [Abstract][Full Text] [Related]
6. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
Phadke K; Carroll J; Nanda S
Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
[TBL] [Abstract][Full Text] [Related]
7. Suppression of type II collagen-induced arthritis by a new isocoumarin, NM-3.
Agata N; Hirano S; Abe C; Nakashima T; Tsuchiya A; Kumagai H; Isshiki K; Yoshioka T; Ishizuka M; Takeuchi T
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):297-309. PubMed ID: 11958283
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
[TBL] [Abstract][Full Text] [Related]
9. Bacopa monniera (L.) wettst inhibits type II collagen-induced arthritis in rats.
Viji V; Kavitha SK; Helen A
Phytother Res; 2010 Sep; 24(9):1377-83. PubMed ID: 20309843
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats.
García-González A; Lotz M; Ochoa JL
Rev Invest Clin; 2009; 61(3):212-20. PubMed ID: 19736810
[TBL] [Abstract][Full Text] [Related]
11. Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats.
Lee JC; Dimartino MJ; Votta BJ; Hanna N
J Immunol; 1987 Nov; 139(10):3268-74. PubMed ID: 3500212
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.
Grosios K; Wood J; Esser R; Raychaudhuri A; Dawson J
Inflamm Res; 2004 Apr; 53(4):133-42. PubMed ID: 15060719
[TBL] [Abstract][Full Text] [Related]
13. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
Yu L; Ao M; Wan J; Zhang Y
Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis.
Pratibha N; Saxena VS; Amit A; D'Souza P; Bagchi M; Bagchi D
Int J Tissue React; 2004; 26(1-2):43-51. PubMed ID: 15573692
[TBL] [Abstract][Full Text] [Related]
16. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
Oikawa T; Sasaki M; Inose M; Shimamura M; Kuboki H; Hirano S; Kumagai H; Ishizuka M; Takeuchi T
Anticancer Res; 1997; 17(3C):1881-6. PubMed ID: 9216639
[TBL] [Abstract][Full Text] [Related]
19. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2007 Mar; 559(2-3):219-26. PubMed ID: 17250824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
